- Somatic mosaicism, from development and ageing, produces genetic heterogeneity that challenges the uniform genome assumption.
- Developmental mosaic mutations are established contributors to neurodevelopmental disorders and increasingly implicated in adult-onset ALS and Alzheimer's disease.
- Postnatal clonal expansions in microglia and haematopoietic cells may drive systemic inflammation, neuronal vulnerability, disease heterogeneity and sporadic neurodegenerative pathogenesis.
Trends Genet. 2026 Nov 17:S0168-9525(26)00263-5. doi: 10.1016/j.tig.2026.10.004. Online ahead of print.
ABSTRACT
Classical genetic studies have assumed a uniform genome across the body, but humans are genetic mosaics harboring distinct somatic mutations acquired during development and aging. The role of somatic mosaicism in neurodegenerative disease remains poorly understood. In this article, we review somatic mosaicism in two contexts: developmental mosaics arising during embryogenesis and age-associated clonal expansions. Developmental mosaics are established contributors to neurodevelopmental disorders, with emerging evidence linking them to adult-onset neurodegeneration, including amyotrophic lateral sclerosis and Alzheimer’s disease. Postnatal clonal expansions in microglia and hematopoietic cells may further promote systemic inflammation and disease progression. We synthesize these findings into a framework in which developmental and age-acquired mutations contribute to neuronal vulnerability, disease heterogeneity, and the pathogenesis of sporadic neurodegenerative disorders.
PMID:43045628 | DOI:10.1016/j.tig.2026.10.004
Share Evidence Blueprint
Save to Google Notes

Search Google Scholar
⭐ My Revision List

